Heska (Restricted Voting) 

$119.99
2
+$0.05+0.04% Monday 20:00

统计

当日最高
-
当日最低
-
52周高点
-
52周低点
-
成交量
-
平均成交量
-
市值
1.3B
市盈率
-44.92
股息率
-
股息
-

股息

0%股息率
Oct 12
$0.1
Jul 12
$0.1
Apr 12
$0.1
10年增长
不适用
5年增长
不适用
3年增长
不适用
1年增长
不适用

财报

7Aug预期
Q4 2021
Q1 2022
Q2 2022
Q3 2022
Q4 2022
Q1 2023
Q2 2023
-0.97
-0.46
0.04
0.55
预期EPS
-0.22
实际EPS
不适用

财务

-7.45%利润率
未盈利
2017
2018
2019
2020
2021
2022
323.65M营收
-24.11M净利润

其他人也在关注

此列表基于在 Stock Events 上关注 HSKA 的用户自选生成。这不是投资建议。

竞争对手

此列表为基于近期市场事件的分析。并非投资建议。

关于

Health Technology
Medical Specialties
Manufacturing
Biological Product (except Diagnostic) Manufacturing
Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element RC, Element RCX, and Element RC3X chemistry systems for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus veterinary hematology analyzers to measure blood cell and platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and Element COAG and Element AIM veterinary analyzers. It also provides HeskaView Telecytology that provides in-clinic automated microscopic slide scanning and computing equipment; IV infusion pumps; digital radiography hardware and mobile digital radiography products; ultrasound systems; Cloudbank, a Web-based image storage solution; point-of-care products to detect antigens and antibodies associated with infectious and parasitic diseases of animals; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels, and therapy shots or drops. In addition, the company provides a line of bovine vaccines; biological and pharmaceutical products to other animal health companies; and turnkey services comprising research, licensing, production, labeling, and packaging; and validation support and distribution services. It sells its products to veterinarians through a telephone sales force, and third-party distributors; and trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. The company was founded in 1988 and is based in Loveland, Colorado.
Show more...
首席执行官
Kevin Wilson
员工
655
国家
US
ISIN
US42805E3062
WKN
000A1H5J3

上市

0 Comments

分享你的想法

FAQ

Heska (Restricted Voting) 今天的股价是多少?
HSKA 当前价格为 $119.99 USD,过去 24 小时上涨了 +0.04%。在图表上更密切关注 Heska (Restricted Voting) 股价表现。
Heska (Restricted Voting) 的股票代码是什么?
根据交易所不同,股票代码可能会有所不同。例如,在 交易所,Heska (Restricted Voting) 的股票以代码 HSKA 进行交易。
Heska (Restricted Voting) 的市值是多少?
今天 Heska (Restricted Voting) 的市值为 1.3B
Heska (Restricted Voting) 去年的营收是多少?
Heska (Restricted Voting) 去年的营收为 323.65MUSD。
Heska (Restricted Voting) 去年的净利润是多少?
HSKA 去年的净收益为 -24.11MUSD。
Heska (Restricted Voting) 会发放股息吗?
是的,HSKA 的股息每 每季度 发放一次。每股最新股息为 0.1 USD。截至今日,股息率(FWD)% 为 0%。
Heska (Restricted Voting) 有多少名员工?
截至四月 01, 2026,公司共有655名员工。
Heska (Restricted Voting) 属于哪个行业?
Heska (Restricted Voting)从事于Manufacturing行业。
Heska (Restricted Voting) 何时完成拆股?
Heska (Restricted Voting) 最近没有进行任何拆股。
Heska (Restricted Voting) 的总部在哪里?
Heska (Restricted Voting) 的总部位于 US 的 Loveland。